bibliographic entry 8105465 [be/8105465]
https://w3id.org/oc/corpus/be/8105465

is a
content
  • Moreau P, Pylypenko H, Grosicki S, Karamanesht I, Leleu X, Grishunina M et al. Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study. Lancet Oncol 2011; 12: 431–440. PMID: 21507715
references